Avita Medical Enrolls First Patients in ReCell(R) Trial for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Avita Medical Enrolls First Patients in ReCell(R) Trial for Chronic Leg Ulcers

NORTHRIDGE, CA and CAMBRIDGE, UK--(Marketwired - Aug 1, 2013) - Avita Medical Ltd. ( ASX : AVH ) ( PINKSHEETS : AVMXF ) ( OTCQX : AVMXY )

  • 65-Patient, Randomized, Controlled Study of Venous Leg Ulcers at up to Five European Centres
  • Leg Ulcers Characterised by High Treatment Costs; Major Burden on Patients and Health Care Systems
  • Large and Growing Market in Need of New Treatment Options; US$25 Billion Lower Limb Management Market in US
  • Significant New Market Opportunity for ReCell

Regenerative medicine Company Avita Medical Ltd. ( ASX : AVH ) ( PINKSHEETS : AVMXF ) ( OTCQX : AVMXY ) announced the initial enrollment of three patients in the RESTORE trial, a multi-centre, randomized European clinical trial evaluating the use of ReCell® Spray-on Skin® in the management of patients with venous leg ulcers. The company believes the management and treatment of lower limb ulcers (LLUs) represents a large and growing market opportunity for ReCell.

LLUs: A Significant and Costly Healthcare Problem

Lower limb ulcers (LLUs), which include venous leg ulcers (VLU) and diabetic foot ulcers (DFU), are a major healthcare problem in developed countries due to their prevalence, high cost of treatment and significant impact on patient quality of life. LLUs afflict nearly 1.5% of the general population in OECD countries and up to 3% over the age of 70 years. Venous ulcers account for 75-85% of all leg ulcers and are anticipated to increase in prevalence with the growing elderly population.

The expense of treating LLUs imposes a major financial burden on healthcare systems globally. In the US alone over 6.5 million people suffer from LLUs with associated treatment cost estimated in excess of US$25 billion; the UK National Health Service (NHS) estimate cost of treatment of LLUs at £2-3 billion per year with similar prevalence and expense documented throughout other European countries. The costs to patients include associated morbidity, pain, lack of mobility and lost work days and wages.

Current treatment options include compression therapy, skin grafts and regular dressing changes; however, such options are costly and there is currently no effective or definitive treatment for LLUs. ReCell offers a promising potential to address this major unmet clinical need.

ReCell: The RESTORE Study The RESTORE study is a randomized, controlled trial designed to evaluate the effectiveness of ReCell for the treatment of chronic venous leg ulcers and is targeting enrollment of 65 patients. The study is based on positive preliminary results achieved with the use of ReCell in the treatment of over 50 VLU patients as previously published (e.g., Giraldi et al, 2012; De Angelis et al, 2013).

The initial three patients in the RESTORE study, each of which have had unhealed ulcers for a minimum of 12 months, were enrolled under Investigator Mr Paul Hayes, consultant vascular and endovascular surgeon at the Addenbrooke's Hospital in Cambridge, UK. Following a two-week observation period, patients will be randomly assigned for treatment with ReCell or the current standard of care and will be followed for a minimum of 12 weeks post-treatment. It is anticipated that additional study centres in Denmark, France and Germany will participate in the trial.

"Chronic wounds, of which venous leg ulcers are the most common, are a major burden to patients, health care professionals, and health care systems globally," said William Dolphin, CEO of Avita Medical. "Preliminary results with the use of ReCell have been extremely encouraging and we are confident that this study will demonstrate the clinical efficacy of ReCell in treating lower limb ulcers. Chronic wounds represent a large and growing market throughout the world and we believe that ReCell will provide an important treatment option for a large segment of this population. The chronic wound market represents a major market opportunity for the company and one for which there is currently no effective solution."

ABOUT AVITA MEDICAL LTD. Avita Medical ( http://www.avitamedical.com/ ) develops and distributes regenerative products for the treatment of a broad range of wounds, scars and skin defects. Avita's patented and proprietary tissue‐culture, collection and application technology provides innovative treatment solutions derived from a patient's own skin. The Company's lead product, ReCell® Spray‐On Skin™, is used in a wide variety of burns, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE‐marked for Europe, TGA‐registered in Australia, and SFDA‐cleared in China. ReCell is not available for sale in the United States; in the U.S. ReCell is an investigational device limited by federal law to investigational use. A Phase III FDA trial is in process.

FOR FURTHER INFORMATION: Contact: Avita Medical Ltd. Sharoni Billik Investor Relations Northridge CA, 91324 USA Phone:+1 818 827-1675 Email: sbillik@avitamedical.com Investor Relations: Philip Capital Sean Kennedy Melbourne VIC 3000 Australia Phone: +61 3 8633 9836 Email: skennedy@phillipcapital.com.au

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Volta M100 Puts Flexibility at Pad Printing's Center

Updated Category News Views 18

A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 135

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Boat Market Forecast Puts Services in the Driver’s Seat

Updated Category News Views 37

A jet ski is not exactly a sober economic indicator, yet the water is telling a useful story. MarketsandMarkets projects the global recreational boat market will rise from $31.38 billion in 2026 to $48.06 billion in 2033, a 6.3% compound annual growth rate. That is respectable growth for a costly discretionary category that got knocked around by softer purchasing activity...

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 164

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 107

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 87

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 104

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 222

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 46

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 257

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading

Top 5 Most Recently Viewed Articles

TRUBAR Inc. Takes Bold Steps with Personal Care Product Sale

Updated Category News Views 169

TRUBAR Inc. Streamlines Focus with Recent Asset Sale TRUBAR Inc. is making significant moves to streamline its operations and focus on its core identity as a leading provider of plant-based protein products. The company has announced that it has successfully sold the assets related to its personal care product line through its subsidiary, NO BS Life, LLC. This strategic...

Continue Reading
Advancements in Squamous Cell Carcinoma Treatments Unveiled

Updated Category News Views 362

Examining Treatments for Squamous Cell Carcinoma The landscape of squamous cell carcinoma (SCC) treatments is rapidly evolving. This shift is largely driven by the increasing number of diagnosed cases. As public awareness rises and exposure to risk factors like ultraviolet (UV) radiation continues, healthcare professionals and researchers are persistently seeking...

Continue Reading
Millennium Physician Group and IMA Medical Group Unite for Better Care

Updated Category News Views 327

Millennium Physician Group and IMA Medical Group Unite for Better Patient Care In an exciting development for healthcare in Central Florida, Millennium Physician Group has announced its collaboration with IMA Medical Group. This partnership represents a major step forward in expanding value-based, patient-centered care to the local communities. About the New Partnership...

Continue Reading
Innovative Partnership to Revolutionize Osteoporosis Detection

Updated Category News Views 96

Strategic Alliance to Enhance Osteoporosis Awareness Naitive Technologies Ltd., a leader in population health innovation focused on musculoskeletal care, has embarked on an important partnership with Parvizi Surgical Innovation (PSI). This collaboration aims to significantly improve the detection and clinical management of osteoporosis, particularly through the use of...

Continue Reading
Storm and Fire Survivors Unite at U.S. Capitol for Aid

Updated Category News Views 451

Storm and Fire Survivors Unite at U.S. Capitol for Aid Recently, over fifty storm and fire survivors convened at the U.S. Capitol to advocate for robust disaster relief and a more effective recovery system for affected families and communities, in an event organized by Organizing Resilience. These brave individuals came together to share their compelling stories,...

Continue Reading